EMIT II Plus Phencyclidine Assay
The EMIT® II Plus Phencyclidine Assay is intended for the qualitative and semiquantitative analysis of phencyclidine in human urine at a cutoff value of 25 ng/mL. The SAMHSA initial test cutoff level is 25 ng/mL.
EMIT II Plus Phencyclidine Assay
Screen for PCP at a cutoff of 25 ng/mL
Features & Benefits
Phencyclidine, also known as PCP and “angel dust,” is a synthetic drug that was originally developed for its anesthetic properties but is now a drug of abuse used solely for its potent hallucinogenic effects. Phencyclidine is absorbed well and quickly and concentrates in the brain and fatty tissues. It is classified as a Schedule II controlled substance.
The EMIT II Plus Phencyclidine Assay provides:
- Detection of the analog 1-[1-(2-thienyl)-cyclohexyl]piperidine (TCP)
- Excellent precision—all within-lab (total) CVs ≤0.6% or less across the assay range
- Ready-to-use liquid reagents, calibrators, and controls
- >99% correlation to reference method (GC/MS)
Applications are available for the Viva-Jr®, Viva-E®, Viva-ProE®, V-Twin® drug testing systems and AU® Series analyzers.
Technical Specifications
EMIT II Plus Phencyclidine Assay Performance
Assay Principle | Homogeneous Enzyme Multiplied Immonoassay (EMIT) |
Cut-off | 25 ng/mL |
Sample | Urine |
Reagent Stability | Unopened: until expiration date. Onboard instrument: up to 4 weeks |
Calibration Frequency | As indicated by control results |